Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding Study of Remifentanil for LMA Insertion During Induction Using Remimazolam
NCT06289829Completed
- Sponsor
- Yonsei University
- Start
- Apr 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of remifentanil, sponsored by Yonsei University. Primary endpoint: Success/failure of LMA insertion on the first attempt at Day 1. Started Apr 2024; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT06289829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289829.